首页> 美国卫生研究院文献>Therapeutic Advances in Medical Oncology >Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study

【2h】

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study

机译：AbiraTerone醋酸盐加上泼尼松在大型潜在世界队列中转移阉割抗阉割前列腺癌中的抗泼尼松患者的有效性：积累研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Real-world data on chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone plus prednisone are limited, largely deriving from small retrospective studies.

机译：用Abiraaterone Plus Plus indnisone处理的耐化疗 - 天真患者的化疗 - 天真患者（MCRPC）是有限的，主要来自小型回顾性研究。

著录项

期刊名称 Therapeutic Advances in Medical Oncology
作者
Giuseppe Procopio; Vincenzo Emanuele Chiuri; Monica Giordano; Giovanna Mantini; Roberto Maisano; Roberto Bordonaro; Nicola Calvani; Gaetano Facchini; Sabino De Placido; Mario Airoldi; Andrea Sbrana; Donatello Gasparro; Giuseppe Mario Ludovico; Pamela Guglielmini; Emanuele Naglieri; Daniele Fagnani; Massimo Aglietta; Luigi Schips; Patrizia Beccaglia; Alessandro Sciarra; Lorenzo Livi; Daniele Santini;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 13
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：abiraTerone醋酸盐;有效性;转移性阉割抗性前列腺癌;前瞻性研究;现实世界研究;

相似文献

外文文献
中文文献
专利

1. Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-na?ve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE [J] . Daniele Santini, Saverio Cinieri, Donatello Gasparro, Journal of Bone Oncology . 2021,第1期

机译：ABIRATERONE醋酸盐加上泼尼松对ADT失效后化疗-NAαve患者骨周转标志物的影响：意大利现实研究份额的前瞻性分析
2. Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-na?ve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial [J] . Carsten-Henning Ohlmann, Michelle J?schke, Peter Jaehnig, Trials . 2017,第1期

机译：醋酸阿比特龙联合LHRH治疗与醋酸阿比特龙同时保留LHRH治疗进展性，转移性和初治性去势抵抗性前列腺癌（SPARE）的患者：一项随机对照试验的研究方案
3. Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study [J] . Martin Boegemann, Sara Khaksar, Guillaume Bera, BMC Cancer . 2019,第1期

机译：AbiraTerone醋酸盐加上泼尼松用于管理转移性阉割前列腺癌（MCRPC）未经使用的化疗：从大型，国际，真实世界的回顾性队列研究中报告
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE [O] . Daniele Santini, Saverio Cinieri, Donatello Gasparro, 2021

机译：ABIRATERNE醋酸盐加上泼尼松对ADT失效后化疗 - 幼稚MCRPC患者骨周转标志物的影响：意大利现实研究症的前瞻性分析
7. Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone [O] . Charles J. Ryan, Thian Kheoh, Jinhui Li, 2018

机译：预后指数模型用于化疗 - 幼稚转移性阉割抗阉割前列腺癌的无进展生存率醋酸盐加上泼尼松

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study

摘要

著录项

相似文献

相关主题

期刊订阅